Photo taken from: Yousef Zakharia/X
Feb 2, 2024, 12:11
Yousef Zakharia: Combining hypomethylating agent guadecitabine and IO in ccRCC
Yousef Zakharia, Associate Professor of Medicine at The University of Iowa shared a post on X:
“Thrilled to share our clinical trial conducted though Big Ten Cancer Research Consortium in Nature Communications combining hypomethylating agent guadecitabine and IO in ccRCC. Huge team effort in conducting and publishing this IIT.”
Read further.
Source: Yousef Zakharia/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 11:28
Feb 22, 2025, 11:22
Feb 22, 2025, 11:15
Feb 22, 2025, 11:02
Feb 22, 2025, 10:47
Feb 22, 2025, 05:18